White Rabbit’s Commercialisation Engine focuses on transforming groundbreaking research in psychedelic science and mental health into scalable, impactful ventures. Leaning on the deep expertise of our core and advisory team, we serve to wrap the necessary commercial acumen around the sharpest scientific minds, providing the incubatory environment to grow innovative research into successful commercial ventures.
In collaboration with key research partners, primarily a collaboration with the Clinical Psychedelic Lab at Monash University, White Rabbit is developing a robust intellectual property portfolio centred on innovative mental health therapies and treatment models.
White Rabbit’s research team comprises a holistic range of stakeholders from foundational science and clinical researchers to practitioners and policy advisors. Its approach is fundamentally rooted in real world application of research findings to identify and examine solutions that serve patients, clinicians and the wider society. WR’s key strategic partnership is with the Clinical Psychedelic Lab at Monash University.
By translating robust research into pragmatic technological solutions, the team enhances the accessibility of current mental heath solutions. White Rabbit focuses on the technologies of tomorrow with Spatial Computing, AI agents and scalable cloud infrastructure comprising the backbone of its product portfolio.
The White Rabbit Network addresses the critical gap in funding for early-stage mental health ventures, particularly in psychedelic-assisted therapy (PAT), a breakthrough approach with strong clinical promise. As a mission-driven angel network, it connects investors with high-impact startups through curated deal flow and expert support. The network provides capital, investor readiness, ana access to non-traditional funding pathways, such as Australia’s CSF regime, aiming to broaden retail investor access and engage the public with frontier mental health science.
InSight VR (Enosis STX)
The first 3D psychotherapy tool designed for any immersive platform. It aids or replaces the therapy sessions that support psychedelic treatment by providing patients with a personalised, continuous support system.
InSight VR (Enosis STX)
The first 3D psychotherapy tool designed for any immersive platform. It aids or replaces the therapy sessions that support psychedelic treatment by providing patients with a personalised, continuous support system.
Enosis Companion App
A data driven, dynamic dashboard and mobile app that organises and analyses patient data across different psychedelic therapy sessions.
Enosis Lock Box
A secure, automated administering system designed for psychedelic dosing rooms. It enables the remote delivery of rescue medication when necessary—without requiring a qualified medical professional to be on-site.
STx.io, developed by White Rabbit, is the first ever immersive psychotherapy company.
STx.io uses its patented methodology to add another dimension to existing therapies, as well as deliver immersive, engaging, highly effective, novel therapy frameworks.
The methodology for spatial therapeutics is the first of its kind, a fully personalised approach to digital therapeutics (DTx), tailored to spatial computing.
Clinical STx Tool
A personalizable clinical program delivered through a VR tool, currently performed at the flagship clinic in collaboration with VCPS in Australia, with future franchising potential.
STX Practitioner Training
An education program delivered to train and certify STx practitioners of the future.
Clinical STx Hub
A community engagement program centred around ongoing clinical supervision and an STX wiki to share VR-enabled therapeutic techniques and mind exploration ideas.
